Biohaven

Money

Biohaven Stock Soars on Positive Results for Rare Neurological Disease Drug

Key Takeaways Biohaven said its experimental treatment for a rare neurological condition showed “a robust and clinically meaningful” slowing of…

Read More »
Back to top button